Cost Is the Biggest Barrier to Teriparatide Adherence

You've determined that your patient needs Teriparatide — they have severe osteoporosis, they've failed or can't tolerate bisphosphonates, and the evidence clearly supports an anabolic agent. Then they call back a week later: "I can't afford it."

This is one of the most common scenarios in osteoporosis management. Brand-name Forteo runs $3,100–$5,400 per pen without insurance, and even with coverage, copays for specialty medications can be hundreds of dollars per month. When patients can't afford their medication, they don't take it — and for a time-limited, bone-building treatment like Teriparatide, missed doses mean missed opportunity.

This guide covers the savings programs, generic options, and workflow strategies that can help your patients actually fill and stay on their Teriparatide prescriptions.

What Patients Are Actually Paying

Understanding the cost landscape helps you set realistic expectations during the prescribing conversation:

• Brand-name Forteo (Eli Lilly): $3,100–$5,400 per pen (28-day supply) at cash price
• Generic Teriparatide (Teva, Alvogen): Approximately $3,400 per pen at retail; $1,150–$1,900 with discount coupons (GoodRx, SingleCare)
• With commercial insurance: Copays vary widely — from $0 with manufacturer copay cards to $200+ for high-deductible or specialty tier plans
• Medicare Part D: Covered but often placed on specialty tiers. Patients in the coverage gap face significant out-of-pocket costs. Manufacturer copay cards cannot be used by Medicare beneficiaries.

The gap between "covered" and "affordable" is where many patients fall through. Prior authorization adds another barrier — most plans require documentation of bisphosphonate failure or intolerance before approving Teriparatide.

Manufacturer Savings Programs

Forteo Copay Card (Eli Lilly)

For commercially insured patients prescribing brand-name Forteo:

• Eligible patients may pay as little as $4 per month
• Available for patients with commercial (private) insurance
• Not available for patients covered by Medicare, Medicaid, Tricare, or other government programs
• Enrollment is typically done through the Forteo website or by calling Lilly's patient support line
• Your office can help initiate enrollment during the prescribing process

Teva Copay Savings Program

For patients using generic Teriparatide from Teva:

• Teva offers a copay savings program for its generic Teriparatide injection
• Similar eligibility restrictions — commercial insurance only, not government-insured patients
• Check Teva's patient support website for current program details and enrollment

Lilly Cares Foundation Patient Assistance Program

For uninsured or underinsured patients who can't afford Forteo at any price:

• Provides Forteo at no cost to eligible patients
• Income-based eligibility requirements
• Application requires provider involvement — you'll need to complete and sign the application
• Processing time is typically 2-4 weeks
• This is one of the most impactful programs for patients who truly cannot afford treatment

Coupon and Discount Card Options

For patients paying cash or with high copays, discount cards can provide meaningful savings on generic Teriparatide:

• GoodRx: Coupons can bring generic Teriparatide down to approximately $1,150–$1,600 depending on pharmacy
• SingleCare: Similar discount range, sometimes competitive pricing at specific pharmacy chains
• RxSaver, BuzzRx, Optum Perks: Additional options worth checking — prices vary by pharmacy and location

Important note: Discount cards cannot be combined with insurance. They're most useful for uninsured patients or when the cash-with-coupon price is lower than the insurance copay — which happens more often than you'd think with specialty medications.

Direct your patients (or their caregivers) to our patient-facing savings guide for step-by-step instructions.

Generic Alternatives and Therapeutic Substitution

Generic Teriparatide

Generic Teriparatide (from Teva and Alvogen) is bioequivalent to Forteo and significantly less expensive — especially when paired with discount coupons. Key points for your prescribing workflow:

• Write prescriptions as "Teriparatide" rather than "Forteo" to allow generic substitution
• Verify that the patient's specialty pharmacy stocks the generic — not all do
• Generic pens use the same formulation (600 mcg/2.4 mL, 28 doses of 20 mcg)
• Patient injection training is identical

Therapeutic Alternatives

When cost is truly prohibitive and no savings program applies, consider whether a therapeutic alternative might be appropriate:

• Abaloparatide (Tymlos): Another anabolic agent with a similar mechanism. Check if the patient's insurance covers it at a lower tier — formulary placement varies between plans. May have its own manufacturer savings program.
• Romosozumab (Evenity): A 12-month course (monthly injections) that's both anabolic and antiresorptive. Shorter duration means lower total treatment cost for some patients. Not appropriate for patients with cardiovascular risk factors.
• Bisphosphonates as a bridge: If the patient needs time to get financial assistance in place, a short course of bisphosphonate therapy may be reasonable to prevent further bone loss while you sort out access. However, remember that bisphosphonates before Teriparatide may blunt its effect — discuss timing with the patient.

For a detailed comparison of Teriparatide alternatives, see our clinical overview.

Additional Resources

• NeedyMeds (needymeds.org) — Comprehensive database of patient assistance programs, discount cards, and free clinic resources
• RxAssist (rxassist.org) — Directory of pharmaceutical company patient assistance programs
• RxHope (rxhope.com) — Helps patients and providers search for assistance programs by medication

Building Cost Conversations Into Your Workflow

The most effective way to prevent cost-related non-adherence is to address it before the patient leaves your office with a prescription. Here's a practical workflow:

At the Point of Prescribing

1. Name the cost upfront: "Teriparatide is an important medication for your bones, but it's expensive. Let's make sure we find a way to make it affordable before I send the prescription."
2. Check insurance formulary status: Have your staff or prior authorization team verify coverage, tier placement, and whether generic or brand is preferred before sending the prescription.
3. Initiate prior authorization early: Don't wait for the pharmacy to reject the claim. Many EHR systems can flag PA requirements at the point of prescribing.
4. Enroll in savings programs at the visit: Have printed or digital enrollment forms for the Forteo copay card and Lilly Cares PAP ready to go.

At Follow-Up

1. Ask about cost barriers: "Have you been able to fill and use your Teriparatide every day?" Cost is the #1 reason for specialty medication abandonment — if a patient isn't filling, don't assume non-compliance without asking about cost.
2. Reassess savings programs annually: Insurance plans change yearly. A patient who was covered last year may face a higher copay this year. Revisit the conversation at annual reviews.
3. Track adherence: Specialty pharmacies can provide adherence reports. If a patient isn't refilling on time, a proactive call from your office can prevent treatment gaps.

Delegate Where Possible

You don't have to do all of this yourself. Consider assigning cost navigation tasks to:

• Clinical pharmacists
• Social workers
• Prior authorization specialists
• Patient financial counselors

Many specialty pharmacies also have their own patient support teams that can help with benefits verification, copay assistance, and prior authorization. Partner with them.

Final Thoughts

Teriparatide is one of the most effective tools we have for building bone in high-risk osteoporosis patients — but it only works if patients can afford to take it. By proactively addressing cost, leveraging manufacturer programs, prescribing generics when possible, and building financial conversations into your standard workflow, you can significantly improve adherence and outcomes.

The medications work. The savings programs exist. The gap is often just awareness and process — and that's something every practice can fix.

For more clinical resources on Teriparatide, visit Medfinder for Providers. For patient-facing guides, share our resources on saving money on Teriparatide and finding it in stock.